These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9850481)

  • 1. The public health burden of diabetes and the reality of limits.
    Vinicor F
    Diabetes Care; 1998 Dec; 21 Suppl 3():C15-8. PubMed ID: 9850481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes care in middle-income countries: a Caribbean case study.
    Gulliford MC; Alert CV; Mahabir D; Ariyanayagam-Baksh SM; Fraser HS; Picou DI
    Diabet Med; 1996 Jun; 13(6):574-81. PubMed ID: 8799663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope.
    Wu Z; Jin T; Weng J
    Sci China Life Sci; 2019 Jan; 62(1):46-62. PubMed ID: 30267261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of economic analysis to diabetes and diabetes care.
    Zhang P; Engelgau MM; Norris SL; Gregg EW; Narayan KM
    Ann Intern Med; 2004 Jun; 140(11):972-7. PubMed ID: 15172923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national comparisons on barriers and resources for optimal care--healthcare professional perspective.
    Holt RI; Nicolucci A; Kovacs Burns K; Escalante M; Forbes A; Hermanns N; Kalra S; Massi-Benedetti M; Mayorov A; Menéndez-Torre E; Munro N; Skovlund SE; Tarkun I; Wens J; Peyrot M;
    Diabet Med; 2013 Jul; 30(7):789-98. PubMed ID: 23710839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Economic analysis and public health. Why does one need economic evaluation applied to diabetes? What methods does one choose: cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health?].
    Triomphe A
    Diabete Metab; 1993 Dec; 19(5 Suppl):473-6. PubMed ID: 8206181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource utilisation and costs for the treatment of diabetes in the developed world: an economical burden that needs to be solved.
    Jendle JH
    Int J Clin Pract; 2009 Jul; 63(7):980-2. PubMed ID: 19570113
    [No Abstract]   [Full Text] [Related]  

  • 9. [How to manage the cost-efficacy ratio?].
    De Wever A
    Rev Med Brux; 2009 Sep; 30(4):437-40. PubMed ID: 19899391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of human parasitic diseases: Context and overview.
    Molyneux DH
    Adv Parasitol; 2006; 61():1-45. PubMed ID: 16735161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. If diabetes is a public health problem, why not treat it as one? A population-based approach to chronic illness.
    Glasgow RE; Wagner EH; Kaplan RM; Vinicor F; Smith L; Norman J
    Ann Behav Med; 1999; 21(2):159-70. PubMed ID: 10499137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality improvement in diabetes--successful in achieving better care with hopes for prevention.
    Haw JS; Narayan KM; Ali MK
    Ann N Y Acad Sci; 2015 Sep; 1353():138-51. PubMed ID: 26495771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communications for alternative development: towards a paradigm.
    Kothari R
    Dev Dialogue; 1984; (1-2):13-22. PubMed ID: 12313651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes--a global threat.
    Lancet; 2009 May; 373(9677):1735. PubMed ID: 19465209
    [No Abstract]   [Full Text] [Related]  

  • 16. How should developing countries manage diabetes?
    Narayan KM; Zhang P; Williams D; Engelgau M; Imperatore G; Kanaya A; Ramachandran A
    CMAJ; 2006 Sep; 175(7):733. PubMed ID: 17001048
    [No Abstract]   [Full Text] [Related]  

  • 17. Indirect costs of diabetes and its impact on the public finance: the case of Poland.
    Torój A; Mela A
    Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):93-105. PubMed ID: 28796563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in diabetes care in India: sheer numbers, lack of awareness and inadequate control.
    Joshi SR; Das AK; Vijay VJ; Mohan V
    J Assoc Physicians India; 2008 Jun; 56():443-50. PubMed ID: 18822625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes in Africa. Challenges to health care for diabetes in Africa.
    Whiting DR; Hayes L; Unwin NC
    J Cardiovasc Risk; 2003 Apr; 10(2):103-10. PubMed ID: 12668907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach to diabetes prevention and management: The Bhutan experience.
    Dorji T; Yangchen P; Dorji C; Nidup T; Zam K
    WHO South East Asia J Public Health; 2016 Apr; 5(1):44-47. PubMed ID: 28604397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.